August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
April 3, 2023
University of Cincinnati researchers recently published findings in the journal Cancer that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
April 27, 2023
National outlets including U.S. News & World Report highlighted research presented by the University of Cincinnati's Alberto Espay on promising new treatments for Parkinson's disease.
April 6, 2023
U.S. News and World Report highlighted research led by the University of Cincinnati's Jordan Kharofa that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.